The Pasteur Institute of Dakar (IPD) and the African Finance Corporation (IFC) will partner for the construction of a vaccine factory in Senegal.

The US$222 million infrastructure is intended to boost “the IPD’s vaccine manufacturing capacity.” In the short term, it will produce Covid-19 vaccines but, in the medium-term, it will start producing other vaccines, the press release stresses.  In the long-term, the plant will be able to produce 300 million doses of vaccines -both for Covid-19 and other diseases- destined for African countries.

For more information, please see https://www.ecofinagency.com/public-management/2503-43484-senegal-ifc-ipd-ink-222-mln-vaccine-factory-construction-deal